ORPEA extends its leadership in Austria

(PresseBox) (Frankfurt am Main, ) ORPEA, a leading European provider of medium- and long-term care (nursing homes, post-acute and rehabilitation hospitals, psychiatric hospitals and home care services) is today announcing the acquisition of Dr. Dr. Wagner Group in Austria.

ACXIT Capital Partners acted as exclusive financial advisor to ORPEA in this transaction. The parties agreed not to disclose any details of the transaction.

ORPEA extends its leadership position in Austria with the acquisition of the Dr. Dr. Wagner Group

Founded by Dr. Wagner, its current manager, the Dr. Dr. Wagner Group is a leading player in the Austrian market for healthcare institutions, with a presence in post-acute and rehabilitation hospitals as well as in nursing homes. The Group now possesses 18 facilities representing 1,812 beds across 5 regions of Austria. This network boasts all the characteristics sought by ORPEA – a very good reputation (patient and resident satisfaction rate of 96%), an integrated and diversified range of medium- and long- term care facilities with multiple specializations including post-acute care and rehabilitation, recently-built premises (new builds or refurbishments over the past 10 years), a real estate ownership rate of 80% and attractive locations.

The Dr. Dr. Wagner Group posted revenue of €60.0 million in 2016. The transaction remains subject to clearance by the anti-trust authorities.

This acquisition will round out SeneCura’s geographical coverage in Austria and extend its range of care and services across the entire spectrum of medium- and long- term care.

Via its SeneCura local subsidiary, ORPEA has bolstered its leadership in the Austrian private nursing home sector where it now operates 77 facilities with 6,807 beds (279 under construction).
 
Value-creating acquisition

With this deal, ORPEA’s network will grow to 79,838 beds at 775 facilities in 10 countries. Overall, 59% of its beds are now located outside France.

ACXIT Capital Partners, represented by Thomas Klack and his team, acted as exclusive financial advisor, with DORDA acting as ORPEA’s legal counsel in Austria.
 
About ORPEA

Founded in 1989, ORPEA is a European leader in integrated long-term care and post-acute care with a network of 775 healthcare facilities including 79,838 beds (9,371 of them under refurbishment or construction):


33,122 beds in France at 357 facilities (2,409 beds under refurbishment or construction);
46,716 beds outside France (Germany, Austria, Belgium, China, Spain, Italy, Czech Republic, Poland and Switzerland) at 418 facilities (6,962 beds under refurbishment or construction)


ORPEA is listed on Euronext Paris (ISIN: FR0000184798) and member of SBF 120, STOXX Europe 600, MSCI Small Cap Europe and CAC Mid 60 indices. (www.orpea-corp.com)

Transaction Team

Thomas Klack, Managing Partner
Ruta Hildebrand, Executive Director
Stefan Hampker, Associate
Diana Prvulovic, Analyst
Daniel Rival, Analyst

ACXIT Capital Holding GmbH

ACXIT Capital Partners [ACP] is a leading international corporate finance and investment advisory firm for mid-market clients and entrepreneurs in Europe and beyond. Since 1998, ACP offers its clients comprehensive corporate finance advisory services including M&A and capital markets advisory as well as restructuring, equity/debt and strategic advisory. As an independent, privately owned firm we maintain offices in Frankfurt, Berlin, Munich, Zurich, Vienna and Hong Kong as well as strong alliances in France, China, India and the USA. (www.acxit.com)

Diese Pressemitteilungen könnten Sie auch interessieren

News abonnieren

Mit dem Aboservice der PresseBox, erhalten Sie tagesaktuell und zu einer gewünschten Zeit, relevante Presseinformationen aus Themengebieten, die für Sie interessant sind. Für die Zusendung der gewünschten Pressemeldungen, geben Sie bitte Ihre E-Mail-Adresse ein.

Es ist ein Fehler aufgetreten!

Vielen Dank! Sie erhalten in Kürze eine Bestätigungsemail.


Ich möchte die kostenlose Pressemail abonnieren und habe die Bedingungen hierzu gelesen und akzeptiert.